Macrogol 4000 in Treatment of Chronic Functional Constipation of Aged Patients

虞阳,于晓峰,郑松柏,顾同进,王根生
DOI: https://doi.org/10.3969/j.issn.1007-7669.2004.02.010
2004-01-01
Abstract:AIM: To evaluate the effect and safety of macrogol 4000 for the chronic functional co nstipation of aged patients. METHODS: Sixty aged patients with chronic functional constipation were divided into two groups. Fivty-nine patients had completed the treatment. Thirty aged patients in macrogol group received macrogol 4000 10 g, po, bid, while 30 ag ed patients in lactulose group received lactulose 15 mL, po, bid. The time s and shape of defecate, and the symptom improvable rate of bloating, anorexia and def ecate-difficulty were observed. RESULTS: After treatment with macrogol 4000, the rate of defecat e-difficulty reduced from 86 % to 34 % with significant statistic difference (P 0.01 ). The result of the macrogol group was similar to that of the la ctul ose group(P0.05). The dose of the medicine used in macrogol group was lower than that of the lactulose group, but with no significant differences. The rema rkable effective rate and effective rate of macrogol group was 52 % and 17 %, t hat was similiar to that of lactulose group. And the adverse reaction of macrogo l group was 6.9 %, closed to that of lactulose group. CONCLUSION: Macrogol 4000 is effective and safe in the treatment of chronic fu nctional constipation of aged patients.
What problem does this paper attempt to address?